ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,831
Screening encounters
1,962
Diagnostic referrals
377
Outstanding pathways
166

Screening pathway

  1. Screening1,962Encounters
  2. Positive finding661Documented findings
  3. Referral377Diagnostic referrals
  4. Follow-up407Diagnostic visits
  5. Outcome211Resolved pathways

Stage totals use different units. Pending pathways: 166. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2025-11-27, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22

Referral-time risk

No matching referral was available at this observation date.

Screened participants

1831 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1732 · Expanded synthetic participant 1732Site B — Peri-Urban Access Programme
EXP-1733 · Expanded synthetic participant 1733Site C — Rural Outreach Programme
EXP-1734 · Expanded synthetic participant 1734Site B — Peri-Urban Access Programme
EXP-1738 · Expanded synthetic participant 1738Site B — Peri-Urban Access Programme
EXP-1740 · Expanded synthetic participant 1740Site E — Resource-Constrained Navigation Programme
EXP-1742 · Expanded synthetic participant 1742Site A — Urban Referral Hub
EXP-1743 · Expanded synthetic participant 1743Site B — Peri-Urban Access Programme
EXP-1747 · Expanded synthetic participant 1747Site C — Rural Outreach Programme
EXP-1751 · Expanded synthetic participant 1751Site B — Peri-Urban Access Programme
EXP-1756 · Expanded synthetic participant 1756Site C — Rural Outreach Programme
EXP-1757 · Expanded synthetic participant 1757Site D — Community Engagement Programme
EXP-1758 · Expanded synthetic participant 1758Site B — Peri-Urban Access Programme
EXP-1762 · Expanded synthetic participant 1762Site C — Rural Outreach Programme
EXP-1770 · Expanded synthetic participant 1770Site C — Rural Outreach Programme
EXP-1771 · Expanded synthetic participant 1771Site B — Peri-Urban Access Programme
EXP-1774 · Expanded synthetic participant 1774Site D — Community Engagement Programme
EXP-1778 · Expanded synthetic participant 1778Site B — Peri-Urban Access Programme
EXP-1781 · Expanded synthetic participant 1781Site B — Peri-Urban Access Programme
EXP-1785 · Expanded synthetic participant 1785Site D — Community Engagement Programme
EXP-1786 · Expanded synthetic participant 1786Site D — Community Engagement Programme
EXP-1792 · Expanded synthetic participant 1792Site B — Peri-Urban Access Programme
EXP-1793 · Expanded synthetic participant 1793Site B — Peri-Urban Access Programme
EXP-1801 · Expanded synthetic participant 1801Site A — Urban Referral Hub
EXP-1802 · Expanded synthetic participant 1802Site E — Resource-Constrained Navigation Programme
EXP-1808 · Expanded synthetic participant 1808Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
837
HPV DNA
843
Cytology
282

Navigation activity

Barrier documented
308
Contact attempt
548
Navigation intervention
125
Diagnostic booking
451
Diagnostic visit
407

Documented barriers

Contact difficulty
93
Transport difficulty
103
Appointment coordination
112

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.